23andMe cofounder and CEO Anne Wojcicki took a few moments to talk to interviewer Hayley Goldbach at Stanford’s recent Big Data in Biomedicine conference.
The annual conference, which seems to get a little bigger each year, focuses on a sweet spot for 23andMe, the promise that the vast ocean of digital information can help drive breakthroughs in drug development and the personalization of medicine.
Here’s Anne’s interview.
